KR101903690B1 - Chinese medicine composition for treating sexual dysfunction - Google Patents

Chinese medicine composition for treating sexual dysfunction Download PDF

Info

Publication number
KR101903690B1
KR101903690B1 KR1020160069733A KR20160069733A KR101903690B1 KR 101903690 B1 KR101903690 B1 KR 101903690B1 KR 1020160069733 A KR1020160069733 A KR 1020160069733A KR 20160069733 A KR20160069733 A KR 20160069733A KR 101903690 B1 KR101903690 B1 KR 101903690B1
Authority
KR
South Korea
Prior art keywords
parts
weight
ginger
sexual dysfunction
fennel
Prior art date
Application number
KR1020160069733A
Other languages
Korean (ko)
Other versions
KR20170137500A (en
Inventor
란핑 리우
Original Assignee
란핑 리우
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 란핑 리우 filed Critical 란핑 리우
Priority to KR1020160069733A priority Critical patent/KR101903690B1/en
Publication of KR20170137500A publication Critical patent/KR20170137500A/en
Application granted granted Critical
Publication of KR101903690B1 publication Critical patent/KR101903690B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/616Echinodermata, e.g. starfish, sea cucumbers or sea urchins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • A61K36/068Cordyceps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

영지 1 내지 2, 회향 6 내지 15, 생강 6 내지 15, 동충하초 6 내지 15, 개별꽃속 뿌리 2 내지 10, 해삼 2 내지 10, 녹용 1 내지 5 및 음양곽초 2 내지 10 중량부를 포함하는 성기능장애를 치료하기 위한 한의학적 조성물Treatment of sexual dysfunction including Ganoderma 1 to 2, Fennel 6 to 15, Ginger 6 to 15, Cordyceps 6 to 15, Individual flower root 2 to 10, Sea cucumber 2 to 10, Deer antler 1 to 5 and Mortar 2 to 10 parts by weight ≪ RTI ID = 0.0 >

Description

성기능장애를 치료하기 위한 한의학적 조성물{CHINESE MEDICINE COMPOSITION FOR TREATING SEXUAL DYSFUNCTION}TECHNICAL FIELD [0001] The present invention relates to a medicinal composition for treating sexual dysfunction,

본 발명은 한의학 분야에 속하는 성기능장애를 치료하기 위한 한의학적 조성물에 관한 것이다.The present invention relates to a medical composition for treating sexual dysfunction belonging to the field of Oriental medicine.

성기능장애 (기능적 발기부전, 조루, 정액루 등과 같은)는 일반적인 성인 남성 생식기 질환이고, 청년 및 노인에서 주로 발생하며, 허리 쓰림 및 요통, 현기증 및 이명, 추위 민감증(cold intolerance), 무기력, 심계항진(palpitation) 및 숨가쁨 뿐만 아니라 자발적 발한, 성교 이완마비(flaccid paralysis), 조루, 정자감소증(oligospermia), 사정자증(necrozoospermia) 등의 주요 임상적 징후를 갖는다. 성기능장애는 보통 성적 치료, 물리적 치료, 약물 치료, 수술적 치료 등을 통해 치료된다. 한의학 분야에서, 기능적 발기부전은 신장 양기의 결함, 신장 음기의 결함 등에 의해 유발되는 것으로 여겨진다. 한방 약제, 양방 약제(성적 건강 약물인 비아그라) 및 한방 약제와 양방 약제가 혼합된 제제로서, 끊임없이 나타나고 경구 투여되거나 외용할 수 있는 것을 포함하는 전립선염에 대한 다양한 선행 기술이 있는다. 그러나, 현재 성기능장애를 치료하기 위한 특이적인 약제가 없고, 상기 선행 기술에서 약제의 치료적 효과는 만족스럽지 않다.Sexual dysfunction (such as functional erectile dysfunction, premature ejaculation, and semen) is a common adult male genital disease and occurs mainly in young adults and the elderly, and includes back pain and back pain, dizziness and tinnitus, cold intolerance, as well as palpitation and shortness of breath, as well as spontaneous sweating, flaccid paralysis, premature ejaculation, oligospermia, and necrozoospermia. Sexual function disorders are usually treated through sexual, physical, medication, and surgical treatment. In Oriental medicine, functional erectile dysfunction is thought to be caused by defects in the kidney, defects in the kidney, and the like. There is a variety of prior art for prostatitis, including herbal medicines, bilateral medicines (Viagra, a sexual health drug), and combinations of oriental and oriental medicines, which appear constantly and can be administered orally or externally. However, there is currently no specific agent for treating sexual dysfunction, and the therapeutic effect of the agent in the prior art is not satisfactory.

따라서, 전립선염을 치료하기 위한 더 좋은 치료적 효과를 갖는 제제, 특히 비교적으로 적은 독성 및 부작용을 갖는 한방 약제 제제의 강력한 시장 요구가 여전히 존재한다. 지금까지 본 발명의 신규성을 파괴할 수 있는 자료는 없다. 본 발명의 발명자들은 임상적 적용 및 반복되는 입증을 통해 다년간의 치밀한 시험을 수행함으로써 방대한 임상적 관찰 데이터를 수집하였고, 전립선염을 치료하기 위한 더 좋은 효과를 갖는 한의학적 조성물을 얻었으며, 그리하여 본 발명을 완성하였다.Thus, there is still a strong market demand for formulations with better therapeutic efficacy for treating prostatitis, especially herbal pharmaceutical preparations with relatively low toxicity and side effects. There is no data that can destroy the novelty of the present invention. The inventors of the present invention collected vast clinical observational data by conducting years of intensive testing through clinical application and repeated proofs and obtained a medical composition with better effect for treating prostatitis, .

본 발명의 목적은 성기능장애를 치료하기 위한 더 좋은 효과를 갖는 한방학적 조성물을 제공하는 것이다.It is an object of the present invention to provide a herbal composition having a better effect for treating sexual dysfunction.

본 발명은 하기와 같이 달성된다: 원료를 포함하는 성기능장애를 치료하기 위한 한의학적 조성물로서, 상기 원료는 영지(Ganoderme luisant), 회향(Foeniculum vulgare), 생강(Zingiber officinale Rosc), 동충하초(Cordyceps sinensis), 개별꽃속 뿌리(Radix Pseudostellariae), 해삼(Holothurian), 녹용(Corn Cervi Pantotrichum) 및 음양곽초(Herba Epimedii)이다; 더 좋은 치료적 효과를 달성하기 위해, 상기 원료 물질은 구기자(Lycium barbarum) 및 개미와 조합될 수 있다; 그리고 더 좋은 치료적 효과를 달성하기 위해, 지황(Rehmannia Glutinosa), 구자(Semen Allii Tuberosi), 토사자(Semen Cuscutae) 및 도마뱀붙이 (gecko)가 추가될 수 있다.The present invention is accomplished as follows: As a medical composition for treating sexual dysfunction comprising raw materials, said raw materials are selected from the group consisting of Ganoderma luisant, Foeniculum vulgare, Zingiber officinale Rosc, Cordyceps sinensis, Radix Pseudostellariae, Holothurian, Corn Cervi Pantotrichum and Herba Epimedii; To achieve a better therapeutic effect, the raw materials can be combined with Lycium barbarum and ants; Rehmannia Glutinosa, Semen Allii Tuberosi, Semen Cuscutae and gecko can be added to achieve better therapeutic effects.

영지 1 내지 2, 회향 6 내지 15, 생강 6 내지 15, 동충하초 6 내지 15, 개별꽃속 뿌리 2 내지 10, 해삼 2 내지 10, 녹용 1 내지 5 및 음양곽초 2 내지 10 중량부 범위 내에 원료 물질을 포함하는 본 발명의 한의학적 조성물은 좋은 치료적 효과를 가진다.The raw material is contained within the range of 2 to 10 parts by weight of Ganoderma 1 to 2, fennel 6 to 15, ginger 6 to 15, cordyceps 6 to 15, individual flower root 2 to 10, sea cucumber 2 to 10, antler 1 to 5, The inventive composition of the present invention has a good therapeutic effect.

바람직하게는, 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5 및 음양곽초 5 중량부이다.Preferably, it is 5 parts by weight of Ganoderma Lucidum 1, Fennel 7.5, Ginger 10, Cordyceps 10, Individual flower root 5, Sea cucumber 5, Antler 2.5,

본 발명의 한의학적 조성물은 또한, 영지 1 내지 2, 회향 6 내지 15, 생강 6 내지 15, 동충하초 6 내지 15, 개별꽃속 뿌리 2 내지 10, 해삼 2 내지 10, 녹용 1 내지 5, 음양곽초 2 내지 10, 구기자(Lycium barbarum) 2 내지 10 및 개미 6 내지 15 중량부 범위 내 원료 물질을 포함할 수 있다: The oriental medicine composition of the present invention may further comprise at least one or more of Ganoderma 1 to 2, Fennel 6 to 15, Ginger 6 to 15, Cordyceps 6 to 15, Individual flower root 2 to 10, Sea cucumber 2 to 10, Deer antler 1 to 5, , Lycium barbarum 2 to 10 and ants 6 to 15 parts by weight.

바람직하게는, 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5, 음양곽초 5, 구기자 5 및 개미 10 중량부이다.Preferably, the ginger is 1, fennel 7.5, ginger 10, cordyceps 10, individual flower root 5, sea cucumber 5, antler 2.5, oyster 5, gujie 5, and 10 parts by weight of ants.

본 발명의 한의학적 조성물은 또한, 영지 1 내지 2, 회향 6 내지 15, 생강 6 내지 15, 동충하초 6 내지 15, 개별꽃속 뿌리 2 내지 10, 해삼 2 내지 10, 녹용 1 내지 5, 음양곽초 2 내지 10, 구기자 2 내지 10, 개미 6 내지 15, 지황 10 내지 30, 구자 6 내지 15, 토사자 6 내지 15 및 도마뱀붙이 30 내지 80 중량부 내에 원료물질을 포함할 수 있다. The oriental medicine composition of the present invention may further comprise at least one or more of Ganoderma 1 to 2, Fennel 6 to 15, Ginger 6 to 15, Cordyceps 6 to 15, Individual flower root 2 to 10, Sea cucumber 2 to 10, Deer antler 1 to 5, , Roots 2 to 10, ants 6 to 15, rhizomes 10 to 30, guises 6 to 15, soil 6 to 15, and gecko 30 to 80 parts by weight.

바람직하게는, 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5, 음양곽초 5, 구기자 5, 개미 10, 지황 15, 구자 10, 토사자 10 및 도마뱀붙이 50 중량부이다.Preferably, 50 weight% of ginger, 1, fennel 7.5, ginger 10, cordyceps 10, individual flower root 5, sea cucumber 5, antler 2.5, oyster 5, ginger 5, ant 10, Wealth.

원칙적으로는, 본 발명인 한의학적 조성물의 제조 방법은 "신 전통적 한의학적 제제 기술의 시험을 위한 기법적 요구(Technical requirements for study of new traditional Chinese medicine preparation technology)(ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU)"에 기록된 방법에 준하고 현대적 제조 신기술을 이용하여 원료 물질의 주요 활성 성분을 추출하는 것 및 물, 설탕, 전분 등과 같은 일부 첨가물을 첨가하여 캡슐, 과립, 정제, 경구 용액 등의 제형인 한의학적 제제로 만든 것을 포함한다.In principle, the method of producing a medicinal composition of the present invention is "Technical requirements for study of new traditional Chinese medicine preparation technology " (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU) ", extracting the main active ingredients of raw materials by using modern manufacturing technology and adding some additives such as water, sugar, starch, etc. to form capsule, granule, tablet, oral solution ≪ / RTI > and the like.

캡슐과 같은 제형으로 제조된 본 발명의 한의학적 조성물을 1회에 5 내지 6 과립으로써(질병의 심각성에 의존한 의사의 조언에 따라), 1일 3회, 10일의 치료과정으로 투여될 수 있다. 회복 치료 효과는 1 내지 2회 치료과정 후 실질적으로 달성될 수 있고, 1 내지 2회 치료과정의 추가적인 통합치료(consolidation therapy) 후 임상적으로 회복하는 효과가 달성될 수 있다.Capsules of the invention can be administered in a therapeutic regimen of 5 to 6 granules at one time (according to the advice of a physician depending on the severity of the disease), three times a day, 10 days of treatment . Recovery therapy effects can be substantially achieved after one to two treatments and a clinically restorative effect can be achieved after additional consolidation therapy of one to two treatments.

캡슐 제형으로 제조된 본 발명의 한의학적 조성물은 복용하기에 편리하고, 성적 기능을 빠르게 개선시키고, 남성 성기의 정력적 발기를 허용하며, 정자의 활력을 개선시키고, 정자 생존률을 개선시켜 성기능을 개선시키는 치료적 목적을 달성하고 인간 신체의 생리학적 기능을 완전히 회복시킬 수 있다.The inventive composition of the present invention, which is prepared in a capsule form, is convenient to take and has the ability to rapidly improve sexual function, allow energetic erection of male genitalia, improve sperm viability, improve sperm viability and improve sexual function It can attain its objective and completely restore the physiological function of the human body.

본 발명은 임상적 관찰 테스트 및 실험예에 의해서 더 자세하게 설명될 것이다.The present invention will be described in more detail by clinical observation tests and experimental examples.

실시예 1 Example 1 캡슐 제형으로 본 발명의 한의학적 조성물의 제조Preparation of the inventive oriental medicine composition in capsule form

원료 물질을 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5, 및 음양곽초 5 중량부로 무게를 달았다. The raw materials were weighed 1, fennel 7.5, ginger 10, cordyceps 10, individual root 5, sea cucumber 5, antler 2.5,

실시예 2Example 2

실시예 1에 기반하여 구기자 5 및 개미 10 중량부를 첨가하였다.Based on Example 1, 10 parts by weight of guar gum 5 and ant was added.

실시예 3Example 3

실시예 2에 기반하여 지황 15, 구자 10, 토사자 10, 및 도마뱀붙이 50 중량부를 첨가하였다.On the basis of Example 2, 15 parts by weight of sulfur, 10 parts by weight of talc, 10 parts by weight of talc and 50 parts by weight of gecko were added.

원칙적으로, 본 발명의 한의학적 조성물의 제조 방법은 "신 전통 한의학적 연고 기술의 연구를 위한 기법적 요구(Technical requirements for study of new traditional Chinese medicine ointment technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU)"에 기록된 방법에 따르고, 현대적 제조 신기술을 이용하여 원료 물질을 가공하는 단계, 태양에 결과물을 건조하는 단계, 100 메쉬 이상으로 분쇄하는 단계, 및 캡슐로 만들기 위해 캡슐 하우징(housing)으로 결과물을 채우는 단계를 포함한다.In principle, the method of manufacturing a medicinal composition of the present invention is "a technical requirement for study of new traditional Chinese medicine ointment technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU) "according to the method described in " Manufacturing of raw materials using modern manufacturing new technology, drying of the resultant to the sun, crushing to over 100 mesh, and capsule housing ) To fill the resultant.

실시예 4 Example 4 과립의 제형로 본 발명의 한의학적 조성물의 제조Preparation of the inventive oriental medicine composition as a granule formulation

원료 물질을 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5, 및 음양곽초 5 중량부로 무게를 달았다. The raw materials were weighed 1, fennel 7.5, ginger 10, cordyceps 10, individual root 5, sea cucumber 5, antler 2.5,

실시예 5Example 5

실시예 4에 기반하여 구기자 5 및 개미 10 중량부를 첨가하였다.Based on Example 4, 10 parts by weight of guar gum 5 and ant was added.

실시예 6Example 6

실시예 5에 기반하여 지황 15, 구자 10, 토사자 10 및 도마뱀붙이 50 중량부를 첨가하였다.On the basis of Example 5, 15 parts of guinea pig, 10 parts of guacamole and 10 parts of gecko were added.

원칙적으로, 본 발명의 한의학적 조성물을 제조하는 방법은 "신 전통 한의학적 연고 기술의 연구를 위한 기법적 요구(ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU)"에 기록된 방법에 따르고, 현대적 제조 신기술을 이용하여 원료 물질을 가공하는 단계, 태양에 결과물을 건조하는 단계, 100 메쉬 이상으로 분쇄하는 단계, 및 과립으로 만들기 위해 하우징(housing)으로 결과물을 채우는 단계를 포함한다.In principle, the method for producing the inventive oriental medicine composition is in accordance with the method described in " Legal requirement for study of new traditional oriental medicine technique (ZHONG YAO XI YAN JIU DE JI SHU YAO QIU) " , Processing the raw material using modern manufacturing techniques, drying the resultant in the sun, pulverizing to over 100 mesh, and filling the resultant with a housing to make it into granules.

테스트 1 임상적 치료적 효과 관찰 데이터Test 1 Clinical therapeutic effect observation data

1. 임상적 일반적 데이터1. Clinical general data

298명의 환자가 선택되었고, 여기서 42명의 환자가 30세 이하, 45명의 환자가 30 내지 35세 범위, 58명의 환자가 35 내지 40세 범위, 63명의 환자가 40 내지 45세 범위, 및 90명의 환자가 45세 이상이었다. 가장 고령의 환자는 53세였고 가장 젊은 환자는 20세였다; 새로 결혼한 환자가 50명, 1 내지 2년의 결혼 적령기를 갖는 환자가 39명, 2 내지 3년의 결혼 적령기를 갖는 환자가 60명, 및 3년 이상(above)의 결혼 적령기를 갖는 환자가 149명 있었다; 3개월 이하의 질병 과정을 가진 환자가 48명, 3 내지 9개월의 질병 과정을 가진 환자가 75명, 9 내지 18개월의 질병 과정을 갖는 환자가 46명, 및 18개월 이상 질병 과정을 갖는 환자가 109명이었다.298 patients were selected, of which 42 patients were under 30 years, 45 patients were in the range of 30 to 35 years, 58 patients in the range of 35 to 40 years, 63 patients in the range of 40 to 45 years, and 90 patients Was over 45 years old. The oldest patient was 53 years old and the youngest patient was 20 years old; Fifty new married patients, 39 marriages with one to two years of marriageable age, 60 marriages with two to three years of marriageable age, and patients with a marriageable age of three years or more There were 149 people; 48 patients with less than 3 months disease course, 75 patients with 3- to 9-month disease course, 46 patients with 9 to 18 month disease course, and patients with more than 18 months disease course Respectively.

2. 진단적 표준2. Diagnostic Standards

한의학 분야에서, 기능적 발기부전은 신장의 양기 결핍, 신장의 음기 결핍 등에 의해 유발되는 것으로 여겨지고, 상기 신장의 양기는 단지 기능을 나타내나, 상기 신장의 음기는 물질적 기반으로서 역할하고 질병을 유발하는 일차성 요인이다("보통 과한 양기가 있으면 반대로, 보통 불충분한 음기가 있다"는 학위 논문이 중국 고대 의학 과학자- ZHU Danxi에 의해 제기된다). 따라서, 간의-음기 및 신장의-음기의 결함은 임상적이고 실질적인 질병 진단 결과를 따르고 기능적 발기부전의 치료동안 근본적으로 치료되어야 한다.In the field of Oriental medicine, functional erectile dysfunction is thought to be caused by ovarian deficiency of the kidney, deficiency of the kidney, etc., and the renal zygote is merely functional, but the kidney yam serves as the material base and the primary It is a sex factor ("If there is usually excessive Yang, there is usually an insufficient tone," a thesis is posed by Chinese ancient medicine scientist - ZHU Danxi). Thus, defects of the liver-tongue and kidney-tongue follow clinical and substantial disease diagnostic results and must be treated fundamentally during the treatment of functional impotence.

3. 치료적 방법: 성기능장애의 병인론 및 발병기전에 따라, 캡슐 제형으로 제조된 한의학적 조성물이 치료에 사용되는데, 상기 한의학적 조성물(이것은 '성기능장애의 치료를 위한 한의학적 조성물(a Chinese medicine composition for treating sexual dysfunction)' (발명자: WANG Qiuru)을 기본적 처방으로 한다)은 원료 물질인 영지 1 내지 2, 회향 6 내지 15, 개미 6 내지 15, 생강 6 내지 15, 동충하초 6 내지 15, 개별꽃속 뿌리 2내지 10, 해삼 2 내지 10, 녹용 1 내지 5, 음양곽초 2 내지 10, 구기자(Lycium barbarum) 2 내지 10, 지황 10 내지 30, 구자 6 내지 15, 토사자 6 내지 15 및 도마뱀붙이 30 내지 80 중량부를 포함한다. 바람직한 처방을 치료에 따라 채택 한다.3. Therapeutic method: According to the etiology and pathogenesis of sexual dysfunction, a medical composition made from a capsule formulation is used for treatment. The above-mentioned medical composition (which is a Chinese medicine composition for treating (WANG Qiuru) "(inventor: WANG Qiuru) as a basic prescription) is made from the raw materials 1 to 2, fennel 6 to 15, ant 6 to 15, ginger 6 to 15, cordyceps 6 to 15, 10 to 10, Gecko 2 to 10, Deer antler 1 to 5, Mugwort 2 to 10, Lycium barbarum 2 to 10, Zucchini 10 to 30, Guillotine 6 to 15, Tortoise 6 to 15 and 30 to 80 parts by weight of Gecko do. Adopt the preferred prescription according to the treatment.

캡슐 제형으로 제조된 본 발명의 한의학적 조성물은 1회에 5 내지 6 과립으로써, 1일 3회, 10일의 치료과정으로 투여될 수 있다. 회복적 투여 효과는 실질적으로 1 내지 2회 치료과정 후 성취될 수 있고, 1 내지 2회 치료과정의 추가적인 통합치료 후, 임상적으로 치료적인 효과를 달성할 수 있다.The inventive composition of the present invention, which is made into a capsule, can be administered as a 5 to 6 granules at a time, three times a day for 10 days. The effect of a restorative dose can be achieved substantially once or twice after the course of the treatment, and a clinically therapeutic effect can be achieved after an additional co-treatment of the once or twice course of the course.

4. 치료적 효과의 표준 평가4. Standard evaluation of therapeutic effects

회복: 상기 임상적 증상이 사라지고, 성교 및 정기가 정상으로 돌아오고, 정자 생존률이 정상이다.Recovery: The clinical symptoms disappear, sexual intercourse and period return to normal, sperm survival rate is normal.

유의한 효과: 상기 임상적 증상이 사실상 또는 유의하게 완화되고, 성교 및 정기가 유의하게 증진되고, 정자 생존률이 증가한다.Significant effect: the clinical symptoms are substantially or significantly relieved, sexual intercourse and period are significantly improved, and sperm survival rate is increased.

개선: 주관적인 증상이 사라지거나 유의하게 완화되고, 정기 및 기분이 유의하게 개선된다.Improvement: subjective symptoms disappear or significantly relieved, and regularity and mood are significantly improved.

효과없음: 2회 이상의 치료과정 후, 상기 증상이 유의하게 완화되지 않고, 상대적인 다양한 지수(indices)가 유의한 변화를 갖지 않는다.No effect: After two or more treatment courses, the symptoms are not significantly relieved and the relative various indices do not have significant changes.

5. 치료적 결과5. Therapeutic results

1 내지 2회의 종래의(conventional) 치료법의 치료과정 후, 상기 임상적 증상이 빠르게 완화되었다. 회복한 환자의 수는 132명(44.3%)이었고, 유의한 효과를 보인 환자 수는 61명(20.5%)이었고, 효과가 없는 환자의 수는 70명(23.5%)이었다; 따라서, 총 유효 비율은 76.5%이다.After one or two conventional treatment regimens, the clinical symptoms quickly relieved. The number of patients recovered was 132 (44.3%), and the number of patients with a significant effect was 61 (20.5%), and the number of patients with no effect was 70 (23.5%). Thus, the total effective ratio is 76.5%.

1 내지 2회의 추가적인 공고요법 후, 상기 임상적 증상이 빠르게 사라졌고, 신체 체질이 정상으로 돌아갔다. 회복된 환자의 수는 168명(56.4%), 유의한 효과를 보인 환자의 수는 72명(24.2%), 개선된 환자의 수는 42명(14.1%), 효과가 없는 환자의 수는 16명(5.3%)이었다; 따라서, 총 유효 비율은 94.7%이다.After one to two additional adjuvant therapies, the clinical symptoms rapidly disappeared, and the body s body returned to normal. The number of patients recovered was 168 (56.4%), the number of patients with significant effect was 72 (24.2%), the number of patients improved to 42 (14.1%), (5.3%); Thus, the total effective ratio is 94.7%.

Claims (5)

영지(Ganoderme luisant) 1 내지 2 중량부, 회향(Foeniculum vulgare) 6 내지 15 중량부, 생강(Zingiber officinale Rosc) 6 내지 15 중량부, 동충하초(Cordyceps sinensis) 6 내지 15 중량부, 개별꽃속 뿌리(Radix Pseudostellariae) 2 내지 10 중량부, 해삼(Holothurian) 2 내지 10 중량부, 녹용(Corn Cervi Pantotrichum) 1 내지 5 중량부, 음양곽초(Herba Epimedii) 2 내지 10 중량부, 구기자(Lycium barbarum) 2 내지 10 중량부, 개미 6 내지 15 중량부, 지황(Rehmannia Glutinosa) 10 내지 30 중량부, 구자(Semen Allii Tuberosi) 6 내지 15 중량부, 토사자(Semen Cuscutae) 6 내지 15 중량부 및 도마뱀붙이(gecko) 30 내지 80 중량부를 포함하는 성기능장애를 치료하기 위한 한의학적 조성물.1 to 2 parts by weight of Ganoderma luisant, 6 to 15 parts by weight of Fennel vulgare, 6 to 15 parts by weight of ginger (Zingiber officinale Rosc), 6 to 15 parts by weight of Cordyceps sinensis, 2 to 10 parts by weight of Pseudostellariae, 2 to 10 parts by weight of Holothurian, 1 to 5 parts by weight of Corn Cervi Pantotrichum, 2 to 10 parts by weight of Herba Epimedii, 2 to 10 parts by weight of Lycium barbarum, 6 to 15 parts by weight of ants, 10 to 30 parts by weight of Rehmannia glutinosa, 6 to 15 parts by weight of Semen Allii Tuberosi, 6 to 15 parts by weight of Semen Cuscutae and 30 to 30 parts by weight of Gecko 30 To 80 parts by weight of the composition. 청구항 1에 있어서, 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5 및 음양곽초 5 중량부를 포함하는 것인 성기능장애를 치료하기 위한 한의학적 조성물.The medical composition for treating sexual dysfunction according to claim 1, which comprises Ganoderma 1, Fennel 7.5, Ginger 10, Cordyceps 10, Individual flower root 5, Sea cucumber 5, Antler 2.5, 삭제delete 청구항 1에 있어서, 영지 1, 회향 7.5, 생강 10, 동충하초 10, 개별꽃속 뿌리 5, 해삼 5, 녹용 2.5, 음양곽초 5, 구기자 5 및 개미 10 중량부를 포함하는 것인 성기능장애를 치료하기 위한 한의학적 조성물.The medicament for treating sexual dysfunction as set forth in claim 1, which comprises Ganoderma 1, fennel 7.5, ginger 10, cordyceps 10, individual flower root 5, sea cucumber 5, antler 2.5, oyster 5, Composition. 삭제delete
KR1020160069733A 2016-06-03 2016-06-03 Chinese medicine composition for treating sexual dysfunction KR101903690B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160069733A KR101903690B1 (en) 2016-06-03 2016-06-03 Chinese medicine composition for treating sexual dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160069733A KR101903690B1 (en) 2016-06-03 2016-06-03 Chinese medicine composition for treating sexual dysfunction

Publications (2)

Publication Number Publication Date
KR20170137500A KR20170137500A (en) 2017-12-13
KR101903690B1 true KR101903690B1 (en) 2018-10-04

Family

ID=60944575

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160069733A KR101903690B1 (en) 2016-06-03 2016-06-03 Chinese medicine composition for treating sexual dysfunction

Country Status (1)

Country Link
KR (1) KR101903690B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220339235A1 (en) * 2021-12-27 2022-10-27 Chenland Nutritionals Inc. Traditional chinese medicine compound composition with effect of improving male sexual function and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107854568B (en) * 2017-11-28 2021-03-16 汤臣倍健股份有限公司 Composition, preparation method thereof and application thereof in field of improving male sexual function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100688252B1 (en) 2006-04-19 2007-03-02 김용욱 Composition for improving male sexual function
CN101912487B (en) 2010-08-03 2012-11-21 彭树林 Medicament for treating neuroendocrine disturbance, sexual function decline and skin aging

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100688252B1 (en) 2006-04-19 2007-03-02 김용욱 Composition for improving male sexual function
CN101912487B (en) 2010-08-03 2012-11-21 彭树林 Medicament for treating neuroendocrine disturbance, sexual function decline and skin aging

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220339235A1 (en) * 2021-12-27 2022-10-27 Chenland Nutritionals Inc. Traditional chinese medicine compound composition with effect of improving male sexual function and application thereof

Also Published As

Publication number Publication date
KR20170137500A (en) 2017-12-13

Similar Documents

Publication Publication Date Title
CN103263531B (en) Chinese medicine composition for treating prosopalgia and preparation method thereof
KR101903690B1 (en) Chinese medicine composition for treating sexual dysfunction
CN102698014A (en) Chinese medicinal composition for treating bone-related diseases and preparation method and application thereof
CN104027449A (en) Medicament composition for treating rheumatoid arthralgia and hyperostosis and preparation method thereof
CN108295128B (en) Traditional Chinese medicine compound preparation for treating rheumatoid arthritis and preparation method thereof
CN106039109A (en) Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis
CN103301431B (en) Traditional Chinese medicinal preparation for treating glaucoma and preparation method thereof
CN1843421A (en) Rheumatoid disease treating medicine
CN104524247A (en) Pharmaceutical composition for treating migraine and application thereof
CN103908603B (en) A kind of Chinese medicine composition treating gout and preparation method thereof
KR20170136213A (en) Chinese medicine composition
CN104800562A (en) Traditional Chinese medicine composition for treating oral lichen planus and preparation method thereof
CN104274720A (en) Traditional Chinese medicine composition for removing urinary calculus and treating stranguria
CN104800675A (en) Medicament for treating active ulcerative colitis
CN103735725B (en) For treating rheumatismal medicine of pig and preparation method thereof
CN104258113B (en) A kind of Chinese medicine composition for the treatment of cerebral hemorrhage
CN106266833A (en) A kind of Chinese medicine composition treating beriberoid pyretic arthralgia and preparation method
CN105288422A (en) Traditional Chinese medicine preparation used for treating eilema syndromes and preparation method
CN100450529C (en) Chinese medicinal preparation for treating apoplexy sequelae
KR20170130042A (en) Chinese medicine composition for treating sexual dysfunction
CN105288372A (en) Pharmaceutical preparation for curing primary dysmenorrhea accompanied by acne
CN100450538C (en) Chinese medicinal formulation for treating apoplexy sequelae
CN104491454A (en) Traditional Chinese medicine for treating dizziness due to hyperactivity of liver-yang and preparation method of traditional Chinese medicine
CN103550364A (en) Traditional Chinese medicine preparation for treating hysteroptosis
CN114796303A (en) Miao medicine for treating rheumatism and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant